MedPath

Effect of Zinc plus Multivitamin in Attention Deficit Hyperactivity Disorder

Phase 3
Conditions
Attention Deficient Hyperactivity Disorder.
Attention-deficit hyperactivity disorder, unspecified type
F90.9
Registration Number
IRCT20150706023083N4
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Diagnosis of ADHD meeting criteria according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
Stable treatment with methylphenidate
Not receiving supplement before this study
Age range 6-12 years old
Zinc deficiency

Exclusion Criteria

Receiving supplement before this study
Other psychiatric disease like autism, Chronic disease, Taking anticonvulsant
Inability to understand and sign consent

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Appetite. Timepoint: On arrival and after 2, 4, 6, 8, 12 weeks after receiving supplement. Method of measurement: Prepared appetite questionnaire.;Weight changes. Timepoint: On arrival and after 2, 4, 6, 8, 12 weeks after receiving supplement. Method of measurement: Scale.;Body Mass Index. Timepoint: On arrival and after 2, 4, 6, 8, 12 weeks after receiving supplement. Method of measurement: The body mass divided by the square of the body height.
Secondary Outcome Measures
NameTimeMethod
Severity of ADHD symptoms. Timepoint: On arrival and after 2, 4, 6, 8, 12 weeks after receiving supplement. Method of measurement: Parents conners questionnaire.
© Copyright 2025. All Rights Reserved by MedPath